Correlation Between Emaar Misr and Memphis Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Emaar Misr and Memphis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emaar Misr and Memphis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Emaar Misr for and Memphis Pharmaceuticals, you can compare the effects of market volatilities on Emaar Misr and Memphis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emaar Misr with a short position of Memphis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emaar Misr and Memphis Pharmaceuticals.

Diversification Opportunities for Emaar Misr and Memphis Pharmaceuticals

0.32

Correlation Coefficient

Emaar Misr  Memphis Pharmaceuticals

Weak diversification

The 3 months correlation between Emaar and Memphis is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Emaar Misr for and Memphis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Memphis Pharmaceuticals and Emaar Misr is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emaar Misr for are associated (or correlated) with Memphis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Memphis Pharmaceuticals has no effect on the direction of Emaar Misr i.e., Emaar Misr and Memphis Pharmaceuticals go up and down completely randomly.

Pair Corralation between Emaar Misr and Memphis Pharmaceuticals

Assuming the 90 days trading horizon Emaar Misr is expected to generate 11.59 times less return on investment than Memphis Pharmaceuticals. But when comparing it to its historical volatility, Emaar Misr for is 2.75 times less risky than Memphis Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Memphis Pharmaceuticals is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  3,508  in Memphis Pharmaceuticals on September 23, 2024 and sell it today you would earn a total of  1,764  from holding Memphis Pharmaceuticals or generate 50.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Emaar Misr for  vs.  Memphis Pharmaceuticals

Emaar Misr for

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Emaar Misr for are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, Emaar Misr is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Memphis Pharmaceuticals

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Memphis Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Memphis Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Emaar Misr and Memphis Pharmaceuticals

The main advantage of trading using opposite Emaar Misr and Memphis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emaar Misr position performs unexpectedly, Memphis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Memphis Pharmaceuticals will offset losses from the drop in Memphis Pharmaceuticals' long position.

The idea behind Emaar Misr for and Memphis Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.